{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:40:57Z","timestamp":1793313657134,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1038\/s41401-025-01548-0","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T06:52:39Z","timestamp":1745477559000},"page":"2765-2778","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Celastrol inhibits the DPYSL2-JAK\/STAT pathway by targeting mito-IDHs mediated mitochondrial metabolism to exhaust breast cancer"],"prefix":"10.1038","volume":"46","author":[{"given":"Qiao-li","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-ran","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-hua","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan-jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-jie","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-xing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-zhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,24]]},"reference":[{"key":"1548_CR1","doi-asserted-by":"publisher","first-page":"104511","DOI":"10.1016\/j.phrs.2019.104511","volume":"150","author":"AF Abdel-Wahab","year":"2019","unstructured":"Abdel-Wahab AF, Mahmoud W, Al-Harizy RM. Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy. Pharmacol Res. 2019;150:104511.","journal-title":"Pharmacol Res"},{"key":"1548_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nchembio.1712","volume":"11","author":"SE Weinberg","year":"2015","unstructured":"Weinberg SE, Chandel NS. Targeting mitochondria metabolism for cancer therapy. Nat Chem Biol. 2015;11:9\u201315.","journal-title":"Nat Chem Biol"},{"key":"1548_CR3","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1111\/j.1742-4658.2007.05686.x","volume":"274","author":"R Moreno-Sanchez","year":"2007","unstructured":"Moreno-Sanchez R, Rodriguez-Enriquez S, Marin-Hernandez A, Saavedra E. Energy metabolism in tumor cells. FEBS J. 2007;274:1393\u2013418.","journal-title":"FEBS J"},{"key":"1548_CR4","doi-asserted-by":"publisher","first-page":"E7","DOI":"10.1038\/s41586-019-1890-z","volume":"577","author":"M Momcilovic","year":"2020","unstructured":"Momcilovic M, Jones A, Bailey ST, Waldmann CM, Li R, Lee JT, et al. Publisher Correction: In vivo imaging of mitochondrial membrane potential in non-small-cell lung cancer. Nature. 2020;577:E7.","journal-title":"Nature"},{"key":"1548_CR5","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aat0456","volume":"5","author":"JL May","year":"2019","unstructured":"May JL, Kouri FM, Hurley LA, Liu J, Tommasini-Ghelfi S, Ji Y, et al. IDH3alpha regulates one-carbon metabolism in glioblastoma. Sci Adv. 2019;5:eaat0456.","journal-title":"Sci Adv"},{"key":"1548_CR6","doi-asserted-by":"publisher","first-page":"5341","DOI":"10.1002\/cam4.2421","volume":"8","author":"B Du","year":"2019","unstructured":"Du B, Sun T, Li X, Diao Y, Li Y. Effect of IDH3a on glucose uptake in lung adenocarcinoma: A pilot study based on [18F]FDG. Cancer Med. 2019;8:5341\u201351.","journal-title":"Cancer Med"},{"key":"1548_CR7","first-page":"3212","volume":"10","author":"X Liu","year":"2020","unstructured":"Liu X, Qiao Y, Ting X, Si W. Isocitrate dehydrogenase 3A, a rate-limiting enzyme of the TCA cycle, promotes hepatocellular carcinoma migration and invasion through regulation of MTA1, a core component of the NuRD complex. Am J Cancer Res. 2020;10:3212\u201329.","journal-title":"Am J Cancer Res"},{"key":"1548_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47536-6","volume":"15","author":"JJ Li","year":"2024","unstructured":"Li JJ, Yu T, Zeng P, Tian J, Liu P, Qiao S, et al. Wild-type IDH2 is a therapeutic target for triple-negative breast cancer. Nat Commun. 2024;15:3445.","journal-title":"Nat Commun"},{"key":"1548_CR9","doi-asserted-by":"publisher","first-page":"4758","DOI":"10.1038\/onc.2014.411","volume":"34","author":"L Zeng","year":"2015","unstructured":"Zeng L, Morinibu A, Kobayashi M, Zhu Y, Wang X, Goto Y, et al. Aberrant IDH3alpha expression promotes malignant tumor growth by inducing HIF-1-mediated metabolic reprogramming and angiogenesis. Oncogene. 2015;34:4758\u201366.","journal-title":"Oncogene"},{"key":"1548_CR10","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.canlet.2021.08.030","volume":"521","author":"HY Lim","year":"2021","unstructured":"Lim HY, Ong PS, Wang L, Goel A, Ding L, Li-Ann Wong A, et al. Celastrol in cancer therapy: recent developments, challenges and prospects. Cancer Lett. 2021;521:252\u201367.","journal-title":"Cancer Lett"},{"key":"1548_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10111","volume":"6","author":"J Wang","year":"2015","unstructured":"Wang J, Zhang CJ, Chia WN, Loh CC, Li Z, Lee YM, et al. Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum. Nat Commun. 2015;6:10111.","journal-title":"Nat Commun"},{"key":"1548_CR12","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1016\/j.apsb.2021.12.007","volume":"12","author":"P Luo","year":"2022","unstructured":"Luo P, Liu D, Zhang Q, Yang F, Wong YK, Xia F, et al. Celastrol induces ferroptosis in activated HSCs to ameliorate hepatic fibrosis via targeting peroxiredoxins and HO-1. Acta Pharm Sin B. 2022;12:2300\u201314.","journal-title":"Acta Pharm Sin B"},{"key":"1548_CR13","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.chembiol.2022.06.011","volume":"29","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Luo P, Xia F, Tang H, Chen J, Zhang J, et al. Capsaicin ameliorates inflammation in a TRPV1-independent mechanism by inhibiting PKM2-LDHA-mediated Warburg effect in sepsis. Cell Chem Biol. 2022;29:1248\u201359.e6.","journal-title":"Cell Chem Biol"},{"key":"1548_CR14","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.chembiol.2023.05.003","volume":"30","author":"L Huang","year":"2023","unstructured":"Huang L, Zhang J, Wei B, Chen S, Zhu S, Qi W, et al. Small-molecule MHC-II inducers promote immune detection and anti-cancer immunity via editing cancer metabolism. Cell Chem Biol. 2023;30:1076\u201389.e11.","journal-title":"Cell Chem Biol"},{"key":"1548_CR15","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26:139\u201340.","journal-title":"Bioinformatics"},{"key":"1548_CR16","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284\u20137.","journal-title":"OMICS"},{"key":"1548_CR17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.bbrc.2012.10.005","volume":"428","author":"DH Shin","year":"2012","unstructured":"Shin DH, Nam JH, Lee ES, Zhang Y, Kim SJ. Inhibition of Ca2+ release-activated Ca2+ channel (CRAC) by curcumin and caffeic acid phenethyl ester (CAPE) via electrophilic addition to a cysteine residue of Orai1. Biochem Biophys Res Commun. 2012;428:56\u201361.","journal-title":"Biochem Biophys Res Commun"},{"key":"1548_CR18","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s10020-023-00663-0","volume":"29","author":"L Huang","year":"2023","unstructured":"Huang L, Wei B, Zhao Y, Gong X, Chen L. DYNLT1 promotes mitochondrial metabolism to fuel breast cancer development by inhibiting ubiquitination degradation of VDAC1. Mol Med. 2023;29:72.","journal-title":"Mol Med"},{"key":"1548_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02694-8","volume":"9","author":"U Topf","year":"2018","unstructured":"Topf U, Suppanz I, Samluk L, Wrobel L, Boser A, Sakowska P, et al. Quantitative proteomics identifies redox switches for global translation modulation by mitochondrially produced reactive oxygen species. Nat Commun. 2018;9:324.","journal-title":"Nat Commun"},{"key":"1548_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e19896","volume":"9","author":"RS Chasara","year":"2023","unstructured":"Chasara RS, Ajayi TO, Leshilo DM, Poka MS, Witika BA. Exploring novel strategies to improve anti-tumour efficiency: The potential for targeting reactive oxygen species. Heliyon. 2023;9:e19896.","journal-title":"Heliyon"},{"key":"1548_CR21","doi-asserted-by":"publisher","first-page":"6024","DOI":"10.1038\/s41388-020-01412-x","volume":"39","author":"B Lin","year":"2020","unstructured":"Lin B, Li Y, Wang T, Qiu Y, Chen Z, Zhao K, et al. CRMP2 is a therapeutic target that suppresses the aggressiveness of breast cancer cells by stabilizing RECK. Oncogene. 2020;39:6024\u201340.","journal-title":"Oncogene"},{"key":"1548_CR22","doi-asserted-by":"crossref","unstructured":"Abu Rmaileh A, Solaimuthu B, Khatib A, Lavi S, Tanna M, Hayashi A, et al. DPYSL2 interacts with JAK1 to mediate breast cancer cell migration. J Cell Biol. 2022;221:e202106078.","DOI":"10.1083\/jcb.202106078"},{"key":"1548_CR23","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.cmet.2020.06.019","volume":"32","author":"K Vasan","year":"2020","unstructured":"Vasan K, Werner M, Chandel NS. Mitochondrial metabolism as a target for cancer therapy. Cell Metab. 2020;32:341\u201352.","journal-title":"Cell Metab"},{"key":"1548_CR24","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/cr.2017.155","volume":"28","author":"PE Porporato","year":"2018","unstructured":"Porporato PE, Filigheddu N, Pedro JMB, Kroemer G, Galluzzi L. Mitochondrial metabolism and cancer. Cell Res. 2018;28:265\u201380.","journal-title":"Cell Res"},{"key":"1548_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.641432","volume":"9","author":"J Zou","year":"2021","unstructured":"Zou J, Huang R, Chen Y, Huang X, Li H, Liang P, et al. Dihydropyrimidinase like 2 promotes bladder cancer progression via pyruvate kinase M2-induced aerobic glycolysis and epithelial-mesenchymal transition. Front Cell Dev Biol. 2021;9:641432.","journal-title":"Front Cell Dev Biol"},{"key":"1548_CR26","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/s41419-023-06286-x","volume":"14","author":"L Zu","year":"2023","unstructured":"Zu L, He J, Zhou N, Tang Q, Liang M, Xu S. Identification of multiple organ metastasis-associated hub mRNA\/miRNA signatures in non-small cell lung cancer. Cell Death Dis. 2023;14:798.","journal-title":"Cell Death Dis"},{"key":"1548_CR27","doi-asserted-by":"publisher","first-page":"8319","DOI":"10.1002\/cam4.5531","volume":"12","author":"F Li","year":"2023","unstructured":"Li F, Ling Q, Lian J, Chen Y, Hu C, Yang M, et al. Dihydropyrimidinase-like 2 can serve as a novel therapeutic target and prognostic biomarker in acute myeloid leukemia. Cancer Med. 2023;12:8319\u201330.","journal-title":"Cancer Med"},{"key":"1548_CR28","doi-asserted-by":"publisher","first-page":"5316","DOI":"10.1016\/j.csbj.2022.08.070","volume":"20","author":"F Soleymani","year":"2022","unstructured":"Soleymani F, Paquet E, Viktor H, Michalowski W, Spinello D. Protein-protein interaction prediction with deep learning: a comprehensive review. Comput Struct Biotechnol J. 2022;20:5316\u201341.","journal-title":"Comput Struct Biotechnol J"},{"key":"1548_CR29","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1182\/blood.2020006075","volume":"136","author":"LK Meyer","year":"2020","unstructured":"Meyer LK, Verbist KC, Albeituni S, Scull BP, Bassett RC, Stroh AN, et al. JAK\/STAT pathway inhibition sensitizes CD8 T cells to dexamethasone-induced apoptosis in hyperinflammation. Blood. 2020;136:657\u201368.","journal-title":"Blood"},{"key":"1548_CR30","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1158\/1541-7786.MCR-18-0916","volume":"17","author":"TE Escher","year":"2019","unstructured":"Escher TE, Lui AJ, Geanes ES, Walter KR, Tawfik O, Hagan CR, et al. Interaction between MUC1 and STAT1 drives IFITM1 overexpression in aromatase inhibitor-resistant breast cancer cells and mediates estrogen-induced apoptosis. Mol Cancer Res. 2019;17:1180\u201394.","journal-title":"Mol Cancer Res"},{"key":"1548_CR31","doi-asserted-by":"publisher","first-page":"114882","DOI":"10.1016\/j.biopha.2023.114882","volume":"163","author":"C Wang","year":"2023","unstructured":"Wang C, Dai S, Zhao X, Zhang Y, Gong L, Fu K, et al. Celastrol as an emerging anticancer agent: current status, challenges and therapeutic strategies. Biomed Pharmacother. 2023;163:114882.","journal-title":"Biomed Pharmacother"},{"key":"1548_CR32","doi-asserted-by":"crossref","unstructured":"Yu X, Zhu D, Luo B, Kou W, Cheng Y, Zhu Y. IFNgamma enhances ferroptosis by increasing JAK\u2011STAT pathway activation to suppress SLCA711 expression in adrenocortical carcinoma. Oncol Rep. 2022;47:97.","DOI":"10.3892\/or.2022.8308"},{"key":"1548_CR33","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/JLB.3MA1220-815RRR","volume":"110","author":"R Kong","year":"2021","unstructured":"Kong R, Wang N, Han W, Bao W, Lu J. IFNgamma-mediated repression of system xc(-) drives vulnerability to induced ferroptosis in hepatocellular carcinoma cells. J Leukoc Biol. 2021;110:301\u201314.","journal-title":"J Leukoc Biol"},{"key":"1548_CR34","first-page":"528","volume":"14","author":"T Liu","year":"2022","unstructured":"Liu T, Li Q, Xu X, Li G, Tian C, Zhang T. Molecular mechanisms of anti-cancer bioactivities of seaweed polysaccharides. Chin Herb Med. 2022;14:528\u201334.","journal-title":"Chin Herb Med"},{"key":"1548_CR35","first-page":"485","volume":"15","author":"F Kong","year":"2023","unstructured":"Kong F, Wang C, Zhang J, Wang X, Sun B, Xiao X, et al. Chinese herbal medicines for prostate cancer therapy: From experimental research to clinical practice. Chin Herb Med. 2023;15:485\u201395.","journal-title":"Chin Herb Med"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01548-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01548-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01548-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T22:02:38Z","timestamp":1758751358000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01548-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["1548"],"URL":"https:\/\/doi.org\/10.1038\/s41401-025-01548-0","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,24]]},"assertion":[{"value":"25 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}